The mass rollout of weight-loss drugs on the NHS in England began this week as GPs became able to prescribe the drugs for the first time. Some 220,000 people with the ‘greatest need’ are expected to receive Mounjaro, the commercial name for tirzepatide, over the next three years.

In this episode of the Nursing Standard podcast, Lisa Rickers – a registered nurse with more than 15 years’ experience as a bariatric specialist in the NHS – explains that the health benefits of these drugs extend far beyond shedding excess pounds. She also discusses their potential risks, and offers advice for nurses when caring for patients who are using them.

Follow the Nursing Standard podcast on Apple Podcasts, Spotify, Acast or wherever you get your podcasts.

For more episodes of the Nursing Standard podcast, visit rcni.com/podcast

Hosted on Acast. See acast.com/privacy for more information.